CONSORT statement: extension to cluster randomised trials
2004; BMJ; Volume: 328; Issue: 7441 Linguagem: Inglês
10.1136/bmj.328.7441.702
ISSN0959-8138
AutoresMarion Campbell, Diana R Elbourne, Douglas G. Altman,
Tópico(s)Health Systems, Economic Evaluations, Quality of Life
ResumoReports of cluster randomised trials require additional information to allow readers to interpret them accuratelyThe effective reporting of randomised controlled trials has received useful attention in recent years.Many journals now require that reports conform to the guidelines in the Consolidated Standards of Reporting Trials (CONSORT) statement, first published in 1996 1 and revised in 2001. 2 The statement includes a checklist of items that should be included in the trial report.These items are evidence based whenever possible and are regularly reviewed. 3 The statement also recommends including a flow diagram to show the flow of participants from group assignment through to the final analysis.The CONSORT statement focused on reporting parallel group randomised trials in which individual participants are randomly assigned to study groups.However, in some situations it is preferable to randomly assign groups of individuals (such as families or medical practices) rather than individuals.Reasons include the threat of contamination of some interventions (such as dietary interventions) if individual randomisation is used. 4 5Also, in certain settings randomisation by group may be the only feasible method of conducting a trial. 6Trials with this design are variously known as field trials, community based trials, place based trials, or (as in this paper) cluster randomised trials. 7In an earlier discussion paper we considered the implications of the CONSORT statement for the reporting of cluster randomised trials. 8Here we present updated guidance, based on the 2001 revision of the CONSORT statement.
Referência(s)